Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin effects on adipose tissue inflammation
NCT02285985Phase 4Completed
- Sponsor
- Phoenix VA Health Care System
- Start
- Feb 2013
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in obesity, sponsored by Phoenix VA Health Care System. Started Feb 2013; status: completed.
02
Drugs
saxagliptin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02285985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285985.